$ICUI News

UPDATE: FDA Says Aware That ICU Medical Has Issued Customer Communication Recommending Certain Iv Tubing Sets Be Removed From Where They Are Used Or Sold; ICU Medical & FDA Still Assessing Scope Of Potentially High-Risk IV Tubing Sets Issue To Identify Some Models, Lots/UDIs That May Be Affected; As Of May 15, ICU Medical Has Not Reported Any Serious Injuries/deaths Associated With Issue Related To Certain Iv Tubing Sets

Needham Upgrades ICU Medical to Buy, Announces $165 Price Target

5 Must-Read Analyst Questions From ICU Medical’s Q1 Earnings Call

ICUI Q1 Deep Dive: Infusion Systems and Consumables Offset Vital Care Weakness

ICU Medical, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Should ICU Medical’s Q1 Earnings Beat And Return To Profitability Require Action From ICUI Investors?

ICU Medical (ICUI) Q1 2026 Earnings Transcript

Implied Volatility Surging for ICU Medical Stock Options

ICU Medical, Inc. (ICUI) Q1 2026 Earnings Call Transcript

ICU Medical Q1 Earnings Call Highlights

ICU Medical Inc (NASDAQ:ICUI) Beats Q1 2026 Earnings Estimates as Core Segments Show Growth

ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates

ICU Medical (NASDAQ:ICUI) Exceeds Q1 CY2026 Expectations

ICU Medical Announces First Quarter 2026 Results

ICU Medical, Inc. 2026 Q1 - Results - Earnings Call Presentation

ICU Medical Affirms FY2026 GAAP EPS Guidance of $1.03-$1.74 vs $1.73 Est

ICU Medical Affirms FY2026 Adj EPS Guidance of $7.75-$8.45 vs $8.09 Est

ICU Medical Q1 Adj. EPS $1.97 Beats $1.75 Estimate, Sales $530.200M Beat $520.483M Estimate

Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $164